Henkel's goal is to make people's lives easier, better and more beautiful with its brands and technologies. Effectively and strategically conducted Research & Development is the key to successfully turning this vision into reality: Constant innovation ensures that Henkel stays at the forefront of the market and continues to offer its partners and customers leading edge technologies and groundbreaking products. In 2006, Henkel invested 340 Million Euros in Research & Development – 16 Million Euros more than in the previous year.
A dedicated Research & Development division of Henkel Biomedical is working to develop a range of new synthetic adhesives, based on its core cyanoacrylate technology. These innovative tissue adhesives will provide healthcare professionals around the world with yet more sophisticated methods of wound closure – and bring even more benefits to patients.

> INDERMIL® regular offers a fast, effective and painless alternative to sutures or staples.
> INDERMIL® xsmall minimizes wastage by providing the alternative of a 0.35g ampoule.
> Soft bristle applicator xcontrol ensures perfect control over the flow of adhesive.
> Fine tip cannula xfine allows absolute precision in applying the adhesive.